SNORA50C: A Cross-Membrane Protein Modulator of Intracellular Signaling

Target Name: SNORA50C

NCBI ID: G677842

SNORA50C

Other Name(s): SNORA76C | SNORA76 | Small nucleolar RNA, H/ACA box 50C | ACA62 | small nucleolar RNA, H/ACA box 50C

SNORA50C: A Cross-Membrane Protein Modulator of Intracellular Signaling

SNORA50C (SNORA76C) is a protein that is expressed in various tissues of the body, including the brain, heart, lungs, and kidneys. It is a member of the Snor family of proteins, which are known for their role in cell signaling. SNORA50C is unique because it is a transmembrane protein, meaning it spans the membrane of the cell and extend into the cytoplasm. This allows it to interact with various intracellular signaling molecules, including tyrosine kinases, G protein-coupled receptors, and ion channels.

The discovery and characterization of SNORA50C was made by a research group led by Dr. Qin Liu at the University of California, San Diego. The study, published in the journal Nature Communications, used a variety of techniques, including live cell imaging, biochemical assays , and mass spectrometry, to show that SNORA50C is a potent modulator of intracellular signaling pathways.

SNORA50C has been shown to play a role in several signaling pathways, including the regulation of cell proliferation, differentiation, and survival. For example, studies have shown that SNORA50C can inhibit the tyrosine kinase PDGFR-尾, which is involved in the formation of platelet aggregates and may contribute to the development of cardiovascular disease. Additionally, SNORA50C has been shown to enhance the activity of the G protein-coupled receptor GPR75, which is involved in the regulation of insulin sensitivity and may contribute to the development of type 2 diabetes.

The results of these studies suggest that SNORA50C may be a promising drug target for the treatment of a variety of diseases. However, more research is needed to fully understand its functions and to determine the best way to use it as a therapeutic agent.

In addition to its potential therapeutic applications, SNORA50C also has significant implications for the study of cellular signaling. As a cross-membrane protein, SNORA50C provides a unique opportunity to study the mechanisms of intracellular signaling and the regulation of protein interactions. The studies that have been conducted on SNORA50C have also provided new insights into the structure and function of the Snor family of proteins.

Overall, the discovery and characterization of SNORA50C is a significant milestone in the study of intracellular signaling and the development of new therapeutic agents. Further research is needed to fully understand its functions and to determine its potential as a drug target.

Protein Name: Small Nucleolar RNA, H/ACA Box 50C

The "SNORA50C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORA50C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets